EUVIMEDOpdag EUVIMED
Systematische ÜbersichtOpen access · CC BY-NC-ND 4.0

Systematic review: the role of frailty in advanced chronic liver disease

Sarah P Bowers iD, Paul N Brennan, John F Dillon

Alimentary Pharmacology & Therapeutics · 2023-02 · 57 (3) · 280-289

DOI: 10.1111/apt.17324 ↗

At a glance

Systematische Übersicht in Alimentary Pharmacology & Therapeutics, published online on 2022-11-25. Written by Sarah P Bowers and 2 co-authors. Institution: NHS Tayside, Ninewells Hospital and Medical School, Dundee, UK. Major MEDLINE topics: Frailty, Liver Diseases, Liver Transplantation. Cited 15 times so far (Crossref); 64 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Frailty is a known predictor of outcome and mortality in patients undergoing liver transplantation. However, most patients remain unsuitable transplant candidates. It is not yet known if the assessment of frailty in non‐transplant candidates can aid prognostication.

Aim

To collate and interrogate the various frailty tools presently used to predict mortality in the non‐transplant cirrhosis setting.

Methods

A comprehensive review of MEDLINE and EMBASE databases for articles published from inception to March 2022 was undertaken, excluding those where patients underwent transplantation or had hepatocellular carcinoma.

Results

We identified 12 observational cohort studies, featuring 9 frailty indices. These were from various global healthcare settings and of fair or good quality. Most were objective tools utilising clinician‐based assessments. All frailty scores predicted prognosis, with variability in the method of application, and utilisation in long‐ or short‐term mortality. Three studies directly compared different indices in the same population. There was some evidence that simple tools could perform as well, if not better, than more complex, time‐consuming scores.

Conclusions

Various frailty tools can reproducibly evaluate mortality in patients with cirrhosis who are ineligible for transplant. However, further prospective head‐to‐head comparative studies are needed. In addition to determining model utility, studies should focus on important relative considerations which may limit widespread implementation including, ease of use and limited resources, given the global disparity of liver care provision. These tools may positively identify specific patient cohorts at risk of impending deterioration, thereby stratifying those patients likely to benefit from early integration with palliative care.

Subjects

MeSH terms (MEDLINE)

FrailtyLiver DiseasesLiver TransplantationHumansLiver CirrhosisCohort Studies

Authors and institutions

  • NHS Tayside, Ninewells Hospital and Medical School, Dundee, UK.
  • Department of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.
  • Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.

ORCID profiles: Sarah P Bowers

Cite

APA

Bowers, S. P., Brennan, P. N., & Dillon, J. F. (2023). Systematic review: the role of frailty in advanced chronic liver disease. Alimentary Pharmacology & Therapeutics, 57(3), 280-289. https://doi.org/10.1111/apt.17324

Vancouver

Bowers SP, Brennan PN, Dillon JF. Systematic review: the role of frailty in advanced chronic liver disease. Alimentary Pharmacology & Therapeutics. 2023;57(3):280-289. doi:10.1111/apt.17324

BibTeX
@article{Bowers2023,
  author = {Bowers, Sarah P and Brennan, Paul N and Dillon, John F},
  title = {Systematic review: the role of frailty in advanced chronic liver disease},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2023},
  volume = {57},
  number = {3},
  pages = {280--289},
  doi = {10.1111/apt.17324}
}
Start for free →